Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Purinergic Signalling|July 15, 2023
EU COST Action CA21130 PRESTO 'P2X receptors as therapeutic targets' inaugural meeting reportLuke Tattersall, Ankita Agrawal, Elena Adinolfi, et al.Purinergic Signalling|February 20, 2024
Preclinical and clinical aspects of P2X receptors as a common route in different diseases: A meeting reportLuke Tattersall, Elena Adinolfi, Luca Antonioli, et al.Purinergic Signalling|June 27, 2026
The effect of P2RX7 functional SNPs on osteoblast cell phenotype, function and signalling- roles in bone homeostasis and osteogenesisLuke Tattersall, Qiguang Wang, Anna Lisa Giuliani, et al.Oncogene|November 26, 2022
The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic reviewVictoria L Tippett, Luke Tattersall, Norain B Ab Latif, et al.Frontiers in Bioscience (Landmark Edition)|April 25, 2022
A Systematic Review of the Expression, Signalling and Function of P2 Receptors in Primary Bone CancerLuke Tattersall, Dan C Gagui, Victoria L Tippett, et al.Iscience|March 27, 2024
The RNA binding proteins LARP4A and LARP4B promote sarcoma and carcinoma growth and metastasisJennifer C Coleman, Luke Tattersall, Val Yianni, et al.Journal of Bone Oncology|March 28, 2022
The P2RX7B splice variant modulates osteosarcoma cell behaviour and metastatic propertiesLuke Tattersall, Karan M Shah, Darren L Lath, et al.Journal of Bone Oncology|March 20, 2023
YBX1-interacting small RNAs and <i>RUNX2</i> can be blocked in primary bone cancer using CADD522Darrell Green, Archana Singh, Victoria L Tippett, et al.Pageof 1